Lipella Pharmaceuticals I... (LIPO)
undefined
undefined%
At close: undefined
2.55
-2.67%
Pre-market Dec 16, 2024, 07:29 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 449.62K 184.16K 259.35K 961.68K 694.75K
Cost of Revenue 3.04M 2.55M 1.46M 975.96K 682.89K
Gross Profit -2.59M -2.36M -1.20M -14.28K 11.86K
Operating Income -4.75M -2.59M -1.92M -56.86K -53.79K
Interest Income 137.84K 1.68K 104.00 3.17K 334.00
Pretax Income -4.62M -2.60M -1.87M -61.66K -61.85K
Net Income -4.62M -2.60M -1.87M -66.45K -61.85K
Selling & General & Admin 2.16M 226.19K 718.38K 42.59K 65.65K
Research & Development 3.04M 2.55M 1.46M 975.96K 682.89K
Other Expenses - -45 57.09K - -
Operating Expenses 2.16M 2.77M 2.18M 1.02M 748.54K
Interest Expense 10.85K 9.61K 6.83K 7.96K 8.39K
Selling & Marketing Expenses - - - - -
Cost & Expenses 5.20M 2.77M 2.18M 1.02M 748.54K
Income Tax - -1.63K 6.73K 4.79K -53.79K
Shares Outstanding (Basic) 6.00M 5.74M 5.74M 5.69M 5.69M
Shares Outstanding (Diluted) 6.00M 5.74M 5.74M 5.69M 5.69M
EPS (Basic) -0.77 -0.45 -0.33 -0.01 -0.01
EPS (Diluted) -0.77 -0.45 -0.33 -0.01 -0.01
EBITDA -4.61M -2.59M - -53.69K 334.00
Depreciation & Amortization 1.69K 2.59M 1.92M 56.86K 53.79K